Invivyd IVVD
NASDAQ IVVD
$0.82 -0.05 (-6.16%)
At close: Oct 1, 2026 · 4:00 PM EDT

Invivyd (IVVD) Net Margin (2024 - 2026)

Updated

Invivyd (IVVD) recorded Net Margin of -310.77% in Q2 2026, down 186.38 percentage points from -124.38% a year earlier.

Analysis

Invivyd (IVVD) Net Margin (2024 - 2026) Analysis & Trends

On a TTM basis, Invivyd's Net Margin came in at -142.90% as of Jun 30, 2026, up 95.43 percentage points year-over-year; for FY2025, it was -98.27%, up 571.15 percentage points from FY2024.

  • Across earlier years, Net Margin came in at -669.42% in FY2024.
  • The Q2 2026 figure is the lowest quarterly Net Margin since Q3 2024.
  • On a year-over-year basis, Net Margin rose in three of the last four quarters, with an average year-over-year change of +604.63 percentage points.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 21.86%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 21.27%
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -8.04%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 22.61%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 18.81%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 23.62%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -134.51%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -1.65%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 32.99%
10 Invivyd 256.44 Mn -250.20 Mn 13.01 Mn -310.77%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -310.77%
Dec 31, 2025 -64.40%
Sep 30, 2025 -79.75%
Jun 30, 2025 -124.38%
Mar 31, 2025 -144.10%
Dec 31, 2024 -133.45%
Sep 30, 2024 -653.11%
Jun 30, 2024 -2,086.88%
API Access

Invivyd Net Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-margin&ticker=IVVD&period=max&api_key=YOUR_API_KEY